Bifogade filer
CLS - Rights issue outcome and focus on neurosurgery
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2024-07-02 08:21:00
Redeye provides an update as we resume our coverage after CLS’ rights issue. We adjust our model accordingly to the rights issue outcome, make estimate changes following the company’s increased focus on neurosurgery, and comment on CLS’ Q1 report. As a result, we provide an updated diluted fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/